FrancophonIA/ELRC3.0 huggingface dataset:
English: If you become pregnant while taking Clopidogrel HEXAL, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.
Slovenian: Če med zdravljenjem z zdravilom Klopidogrel HEXAL zanosite, se takoj posvetujte s svojim zdravnikom, saj jemanje klopidogrela med nosečnostjo ni priporočljivo.
English: Clopidogrel HEXAL is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).
Slovenian: Zdravilo Klopidogrel HEXAL se jemlje za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
English: If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Clopidogrel HEXAL.
Slovenian: Če ste noseči ali mislite, da ste noseči, morate o tem obvestiti svojega zdravnika ali farmacevta, preden vzamete zdravilo Klopidogrel HEXAL.
English: If you forget to take a dose of Clopidogrel HEXAL, but remember within 12 hours of your usual time, take your tablet straight away and then take your next tablet at the usual time.
Slovenian: Če ste pozabili vzeti zdravilo Klopidogrel HEXAL Če pozabite vzeti odmerek zdravila Klopidogrel HEXAL in se nanj spomnite do 12 ur po ustaljenem času, takoj vzemite tableto in nato vzemite naslednjo tableto spet ob ustaljenem času jemanja.
English: INFORMATION IN BRAILLE Clopidogrel HEXAL 75 mg
Slovenian: PODATKI V BRAILLOVI PISAVI Klopidogrel HEXAL 75 mg
English: a recent serious injury a recent surgery (including dental) a planned surgery (including dental) in the next seven days if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the last seven days if you have kidney or liver disease
Slovenian: nedavna huda poškodba nedaven kirurški poseg (vključno na zobeh) načrtovan kirurški poseg (vključno na zobeh) v naslednjih 7 dneh
English: What Clopidogrel HEXAL looks like and contents of the pack
Slovenian: Izgled zdravila Klopidogrel HEXAL in vsebina pakiranja
English: However, if you are concerned by your bleeding, you should contact your doctor straightaway (see section 2 ‘Take special care with Clopidogrel HEXAL').
Slovenian: Vendar pa se morate takoj posvetovati s svojim zdravnikom, če ste glede krvavitve v kakršnihkoli dvomih (glejte poglavje 2 »Bodite posebno pozorni pri jemanju zdravila Klopidogrel HEXAL«).
English: If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Clopidogrel HEXAL (4 tablets of 75 mg) once at the start of treatment.
Slovenian: Če ste imeli hudo bolečino v prsih (nestabilna angina pektoris ali srčna kap), vam lahko zdravnik na začetku zdravljenja da 300 mg zdravila Klopidogrel HEXAL v enkratnem odmerku (štiri 75-mg tablete).
English: signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Take special care with Clopidogrel HEXAL').
Slovenian: To so lahko znaki redkega zmanjšanja števila določenih krvnih celic, - znaki jetrnih težav, kot je porumenelost kože in/ali oči (zlatenica), ki so lahko, ali pa ne, povezani s krvavitvijo, ki se pojavi pod kožo kot drobne rdeče pike, in/ali zmedenostjo (glejte poglavje 2 »Bodite posebno pozorni pri jemanju zdravila Klopidogrel HEXAL«).
English: Excipients Clopidogrel HEXAL contains hydrogenated castor oil which may cause stomach upset and diarrhoea.
Slovenian: Klopidogrel HEXAL vsebuje hidrogenirano ricinusovo olje, ki lahko razdraži želodec in povzroči drisko.
English: How to store Clopidogrel HEXAL Further information
Slovenian: Shranjevanje zdravila Klopidogrel HEXAL Dodatne informacije
English: Do not take Clopidogrel HEXAL:
Slovenian: Ne jemljite zdravila Klopidogrel HEXAL:
English: Important information about some of the ingredients of Clopidogrel HEXAL: Clopidogrel HEXAL contains hydrogenated castor oil which may cause stomach upset or diarrhoea.
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Klopidogrel HEXAL Zdravilo Klopidogrel HEXAL vsebuje hidrogenirano ricinusovo olje, ki lahko povzroči želodčne motnje ali drisko.
English: Clopidogrel HEXAL contains the active ingredient Clopidogrel which belongs to a group of medicines called antiplatelet medicinal products.
Slovenian: Klopidogrel HEXAL vsebuje zdravilno učinkovino klopidogrel, ki spada v skupino zdravil, ki se imenujejo zaviralci agregacije trombocitov.
English: Clopidogrel HEXAL 75 mg film-coated tablets are white to off-white, marbled, round and biconvex.
Slovenian: Klopidogrel HEXAL 75 mg tablete so bele do belkaste, marmorirane, okrogle, bikonveksne filmsko obložene tablete.
English: Alu/Alu blisters containing 14, 28, 30, 50, 84, 90 and 100 film-coated tablets packed in cardboard cartons.
Slovenian: 6.5 Vrsta ovojnine in vsebina Alu/Alu pretisni omoti, ki vsebujejo 14, 28, 30, 50, 84, 90 in 100 filmsko obloženih tablet v kartonskih škatlah.
English: Clopidogrel HEXAL is unlikely to affect your ability to drive or to use machines.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Klopidogrel HEXAL vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
English: HEXAL S.p.A. c/o Sandoz S.p.A. Largo Umberto Boccioni 1 I-21040 Origgio / VA Tel: + 39-02-96 541
Slovenian: Largo Umberto Boccioni 1 I-21040 Origgio / VA Tel: + 39-02-96 541
English: Do not use Clopidogrel HEXAL after the expiry date which is stated on the carton and on the blister after EXP.
Slovenian: Zdravila Klopidogrel HEXAL ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na pretisnem omotu po oznaki EXP. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): clopidogrel treatment should be initiated with a single 300 mg loading dose and then continued at 75 mg once a day (with acetylsalicylic acid (ASA) 75 mg-325 mg daily).
Slovenian: Pri bolnikih z akutnim koronarnim sindromom: - Akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca): zdravljenje moramo začeti z enkratnim udarnim odmerkom 300 mg klopidogrela in nadaljevati s 75 mg enkrat na dan (s 75 mg do 325 mg acetilsalicilne kisline (ASA) dnevno).
English: The number of patients experiencing the co-primary endpoint (CV death, MI, stroke or refractory ischaemia) was 1,035 (16.5%) in the clopidogrel-treated group and 1,187 (18.8%) in the placebo-treated group, a 14% relative risk reduction (95% CI of 6%-21%, p=0.0005) for the clopidogrel-treated group.
Slovenian: Število bolnikov s primarnim opazovanim dogodkom (srčno-žilna smrt, MI, kap ali neodzivna ishemijo) je bilo 1.035 (16,5 %) v skupini zdravljeni s klopidogrelom in 1.187 (18,8 %) v skupini s placebom, to je 14 % zmanjšanje relativnega tveganja (95 % IZ od 6 % - 21 %, p=0,0005) za skupino, zdravljeno s klopidogrelom.
English: Fifteen percent (15.0%) of patients in the clopidogrel group and 21.7% in the placebo group reached the primary endpoint, representing an absolute reduction of 6.7% and a 36% odds reduction in favour of clopidogrel (95% CI: 24, 47%; p< 0.001), mainly related to a reduction in occluded infarct-related arteries.
Slovenian: Primarni opazovani dogodek je bil opažen pri 15,0 % bolnikov v skupini s klopidogrelom in 21¸7 % bolnikov v skupini s placebom, kar predstavlja absolutno zmanjšanje za 6,7 % in 36 % zmanjšanje verjetnosti v prid klopidogrela (95 % IZ od 24 % do 47 %; p<0,001) v glavnem zaradi zmanjšanja zaradi infarkta zamašenih arterij.
English: Patients were randomised to clopidogrel (300 mg loading dose followed by 75 mg/day, N = 6,259) or placebo (N = 6,303), both given in combination with ASA (75-325 mg once daily) and other standard therapies.
Slovenian: Bolniki so bili naključno razporejeni v skupino, ki je prejemala klopidogrel (začetni odmerek 300 mg, nato 75 mg/dan, n=6.259) ali skupino, ki je prejemala placebo (n=6.303), oboje prejeto v kombinaciji z ASA (75 - 325 mg enkrat na dan) in drugimi standardnimi terapijami.
English: Take special care with Clopidogrel HEXAL:
Slovenian: Bodite posebno pozorni pri jemanju zdravila Klopidogrel HEXAL:
English: Patients received clopidogrel (75 mg/day, n = =22,961) or placebo (n==22,891), in combination with ASA (162 mg/day), for 28 days or until hospital discharge.
Slovenian: Bolniki so 28 dni oziroma do odpusta dobivali klopidogrel (75 mg na dan, n=22.961) ali placebo (n=22.891) v kombinaciji z ASA (162 mg na dan).
English: NAME OF THE MEDICINAL PRODUCT Clopidogrel HEXAL 75 mg film-coated tablets
Slovenian: IME ZDRAVILA Klopidogrel HEXAL 75 mg filmsko obložene tablete
English: If any of the situations mentioned below apply to you, you should tell your doctor before taking Clopidogrel HEXAL: if you have a risk of bleeding such as a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer) a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
Slovenian: • če imate tveganje za krvavitev, kot je: zdravstveno stanje s tveganjem za notranjo krvavitev (kot je rana na želodcu) krvna motnja, zaradi katere ste bolj nagnjeni k notranji krvavitvi (krvavitev v tkivih, organih ali sklepih vašega telesa).
English: HOW TO TAKE CLOPIDOGREL HEXAL
Slovenian: KAKO JEMATI ZDRAVILO KLOPIDOGREL HEXAL
English: Clopidogrel HEXAL 75 mg film-coated tablets Clopidogrel
Slovenian: Klopidogrel HEXAL 75 mg filmsko obložene tablete klopidogrel
English: You have a condition of hardening of arteries (also known as atherosclerosis), and You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease (disturbed blood flow in arms or legs caused by vascular occlusions) or
Slovenian: Zdravilo Klopidogrel HEXAL vam je predpisano za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen (moten krvni pretok v rokah ali nogah, ki ga povzroči zapora žil) ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
English: Do not stop the treatment unless your doctor tells you so.
Slovenian: Če ste prenehali jemati zdravilo Klopidogrel HEXAL Ne prekinite zdravljenja razen, če tako odloči zdravnik.
English: Store in the original blister in order to protect from moisture.
Slovenian: POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte v originalnem pretisnem omotu za zagotovitev zaščite pred vlago.
English: Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions; swelling in the mouth; blisters of the skin; skin allergy; inflammation of the mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes in the way things taste.
Slovenian: mehurji na koži, kožna alergija, vnetje v ustih (stomatitis), znižanje krvnega tlaka, zmedenost, halucinacije, bolečine v sklepih, bolečine v mišicah, motnje okusa.
English: Box 53158-3301 Limassol, Cyprus
Slovenian: For P. T. Hadjigeorgiou co ltd Postal address: P.O. Box 53158-3301 Limassol, Cyprus
English: While you are taking Clopidogrel HEXAL:
Slovenian: Ko jemljete zdravilo Klopidogrel HEXAL:
English: 3 years
Slovenian: 6.3 Rok uporabnosti 3 leta.
English: NAME OF THE MEDICINAL PRODUCT Clopidogrel HEXAL 75 mg film-coated tablets Clopidogrel NAME OF THE MARKETING AUTHORISATION HOLDER Acino Pharma GmbH EXPIRY DATE
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM Acino Pharma GmbH
English: HOW TO STORE CLOPIDOGREL HEXAL
Slovenian: Kaj vsebuje zdravilo Klopidogrel HEXAL
English: Thrombocytopenia, leucopenia, eosinophilia
Slovenian: Trombocitopenija, levkopenija,
English: Always take Clopidogrel HEXAL exactly as your doctor has told you.
Slovenian: Pri jemanju zdravila Klopidogrel HEXAL natančno upoštevajte zdravnikova navodila.
English: Further information on Lucentis can be found on the Agency's website:ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Nadaljnje informacije o zdravilu Lucentis so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Lucentis received a marketing authorisation valid throughout the EU on 22 January 2007.
Slovenian: Za zdravilo Lucentis je bilo 22. januarja 2007 izdano dovoljenje za promet, veljavno po vsej EU.
English: What measures are being taken to ensure the safe and effective use of Lucentis?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Lucentis?
English: Treatment with Lucentis should be stopped if the patient is not benefitting from it.
Slovenian: Zdravljenje z zdravilom Lucentis je treba prekiniti, če bolnik od njega nima koristi.
English: The European Medicines Agency decided that Lucentis's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila Lucentis večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: The interval between two injections of Lucentis into the same eye must be at least four weeks.
Slovenian: Razmak med injiciranji zdravila Lucentis v isto oko mora biti vsaj štiri tedne.
English: Other information about Lucentis
Slovenian: Druge informacije o zdravilu Lucentis
English: In both studies, the improvement in vision was maintained over the course of the study.
Slovenian: V obeh študijah se je izboljšanje vida ohranilo skozi celotno študijo.
English: All of the patients were over 50 years of age and had not been treated for wet AMD before.
Slovenian: Vsi bolniki so bili starejši od 50 let in predhodno še niso bili zdravljeni zaradi te bolezni.
English: The macula provides the vision needed to see detail for everyday tasks such as driving, reading and recognising faces.
Slovenian: Makula zagotavlja vid, ki je potreben za zaznavanje podrobnosti med vsakdanjimi opravili, na primer pri vožnji avtomobila, branju in prepoznavanju obrazov.
English: Patients were classified as having experienced no significant worsening of vision if the number of letters that they could see increased, stayed the same, or fell by less than 15.
Slovenian: Bolniki so bili opredeljeni kot bolniki brez znatnega poslabšanja vida, če se je število črk, ki so jih lahko videli, povečalo, ostalo enako oziroma se je zmanjšalo za manj kot 15 črk.
English: The most common side effects with Lucentis (seen in more than 1 in 10 patients) are increased intraocular pressure (pressure within the eye), headache, vitritis (inflammation in the eye), vitreous detachment (separation of the vitreous from the back of the eye), retinal haemorrhage (bleeding at the back of the eye), visual disturbance, eye pain, vitreous floaters (spots in the vision), conjunctival haemorrhage (bleeding at the front of the eye), eye irritation, sensation of a foreign body in the eye, increased lacrimation (tear production), blepharitis (inflammation of the eyelids), dry eye, ocular hyperaemia (red eye), eye pruritis (itching), arthralgia (joint pain) and nasopharyngitis (inflammation of the nose and throat).
Slovenian: Najpogostejši neželeni učinki zdravila Lucentis (opaženi pri več kot 1 bolniku od 10) so povečan intraokularni tlak (tlak v notranjosti očesa), glavobol, vitritis (vnetje v očesu), odstop steklovine (odluščenje steklovine od zadnjega dela očesa), mrežnična krvavitev (krvavitev v zadnjem delu očesa), motnje vida, bolečine v očeh, delci v steklovini (pikice pred očmi), veznična krvavitev (krvavitev v sprednjem delu očesa), draženje oči, občutek tujka v očesu, povečano solzenje, blefaritis (vnetje vek), suho oko, očesna hiperemija (pordelost oči), očesni pruritus (srbenje), artralgija (bolečine v sklepih) in nazofaringitis (vnetje nosu in grla).
English: • other sight problems associated with choroidal neovascularisation;
Slovenian: • drugih težav z vidom, ki so povezane s horoidalno neovaskularizacijo;
English: As for all medicines, data on the use of Lucentis are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Lucentis stalno spremljajo.
English: What benefits of Lucentis have been shown in studies?
Slovenian: Kakšne koristi zdravila Lucentis so se pokazale v študijah?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Lucentis have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Lucentis upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: Why is Lucentis authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Lucentis odobreno v EU?
English: What are the risks associated with Lucentis?
Slovenian: Kakšna tveganja so povezana z zdravilom Lucentis?
English: Side effects reported with Lucentis are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Lucentis, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: An overview of Lucentis and why it is authorised in the EU
Slovenian: Pregled zdravila Lucentis in zakaj je odobreno v EU
English: The prefilled syringe contains more than the recommended dose, therefore when preparing the injection, the doctor must expel the excess volume and ensure the injection of the correct dose.
Slovenian: Napolnjena injekcijska brizga vsebuje večji odmerek od priporočenega, zato mora zdravnik pri pripravi injekcije iztisniti odvečno količino in injicirati ustrezni odmerek.
English: In both studies, the main measure of effectiveness was the change in vision in the affected eye, measured by comparing the number of letters that the patient could see at the end of the treatment period with the number before starting treatment.
Slovenian: V obeh študijah je bilo glavno merilo učinkovitosti sprememba vida prizadetega očesa, kar so merili s primerjanjem števila črk, ki so jih bolniki lahko videli ob koncu zdravljenja, s številom prepoznanih črk pred začetkom zdravljenja.
English: What is Lucentis and what is it used for?
Slovenian: Kaj je zdravilo Lucentis in za kaj se uporablja?
English: After one year, between 94 and 96% of the AMD patients receiving Lucentis every month experienced no significant worsening of their vision, compared with 62% of those receiving sham injections and 64% of those treated with verteporfin PDT.
Slovenian: Pri 94 % do 96 % bolnikov s starostno degeneracijo makule, ki so prejemali zdravilo Lucentis vsak mesec, se vid po enem letu ni znatno poslabšal v primerjavi z 62 % tistih, ki so prejemali navidezne injekcije, in 64 % tistih, ki so se zdravili s fotodinamično terapijo z verteporfinom.
English: A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific target (called an antigen) that is found in certain cells in the body.
Slovenian: Monoklonsko protitelo je protitelo (vrsta beljakovine), ki je bilo zasnovano tako, da prepozna določeno prijemališče (imenovano antigen), ki je prisotno v nekaterih celicah v telesu, in se veže nanj.
English: For more information about using Lucentis, see the package leaflet or contact your doctor or pharmacist
Slovenian: Za več informacij glede uporabe zdravila Lucentis glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: Before each injection, a local anaesthetic is given to reduce or prevent any pain from the injection, and the eye, eyelid and skin around the eye are disinfected.
Slovenian: Pred vsakim injiciranjem je treba bolniku dati lokalni anestetik za zmanjšanje oziroma preprečevanje bolečine ob injiciranju ter razkužiti oko, veko in kožo okoli očesa.
English: Ranibizumab has been designed to attach to and block a substance called vascular endothelial growth factor A (VEGF-A).
Slovenian: Ranibizumab je bil zasnovan tako, da se veže na snov, imenovano vaskularni endotelijski rastni dejavnik A (VEGF-A), in jo zavira.
English: • the ‘wet' form of age-related macular degeneration (AMD).
Slovenian: • vlažne oblike starostne degeneracije makule (AMD).
English: Rarely, endophthalmitis (an infection inside the eye), blindness, serious damage to the retina and cataract (clouding of the lens) can occur.
Slovenian: Redko se lahko pojavijo endoftalmitis (okužba v notranjosti očesa), slepota, huda poškodba mrežnice in katarakta (zameglitev leče).
English: It is given by intravitreal injection (injection into the vitreous humour, the jelly-like fluid in the eye).
Slovenian: Daje se z intravitrealno injekcijo (injiciranjem v steklovino, tj. želatini podobno tekočino v očesu).
English: The conditions Lucentis is used to treat are:
Slovenian: Zdravilo Lucentis se uporablja za zdravljenje naslednjih bolezni:
English: Lucentis was more effective at preventing a worsening of vision than the comparison treatment.
Slovenian: Zdravilo Lucentis je bilo učinkovitejše pri preprečevanju poslabšanja vida kot primerjalno zdravljenje.
English: The recommended dose for Lucentis is 0.5 mg given as a single intravitreal injection.
Slovenian: Priporočeni odmerek zdravila Lucentis je 0,5 mg v obliki ene injekcije v oko.
English: The active substance in Lucentis, ranibizumab, is a small piece of a monoclonal antibody.
Slovenian: Učinkovina v zdravilu Lucentis, ranibizumab, je majhen drobec monoklonskega protitelesa.
English: VEGF-A is a protein that makes blood vessels grow and leak fluid and blood, damaging the macula.
Slovenian: VEGF-A je beljakovina, ki spodbuja rast krvnih žil in iztekanje tekočine in krvi iz njih, kar povzroča poškodbe makule.
English: The wet form of AMD is caused by choroidal neovascularisation (abnormal growth of blood vessels beneath the retina, which may leak fluid and blood and cause swelling);
Slovenian: Vlažno obliko starostne degeneracije makule povzroča horoidalna neovaskularizacija (nenormalna rast krvnih žil pod mrežnico, iz katerih lahko iztekata tekočina in kri, kar povzroči otekanje);
English: The main measure of effectiveness was the change in vision in the affected eye after a year of treatment, using a standard eye test with a letter chart.
Slovenian: Glavno merilo učinkovitosti je bila sprememba vida prizadetega očesa leto dni po zdravljenju, kar so merili s standardnim testom vida na črkovni tabeli.
English: For diabetic macular oedema, Lucentis was studied in two main studies involving a total of 454 patients.
Slovenian: V okviru makularnega edema zaradi sladkorne bolezni so zdravilo Lucentis proučevali v dveh glavnih študijah, ki sta vključevali skupno 454 bolnikov.
English: Three main studies of Lucentis involved 1,323 patients with the wet form of AMD.
Slovenian: V tri glavne študije zdravila Lucentis je bilo vključenih 1 323 bolnikov z vlažno obliko starostne degeneracije makule.
English: A second study involved 178 patients with choroidal neovascularisation associated with other conditions, and compared Lucentis with a sham injection.
Slovenian: V drugi študiji je sodelovalo 178 bolnikov s horoidalno neovaskularizacijo, povezano z drugimi bolezenskimi stanji, v njej pa so zdravilo Lucentis primerjali z navideznimi injekcijami.
English: Two of the studies compared Lucentis with a sham injection ( a procedure similar to a Lucentis injection, in which the syringe is pressed against the surface of the eye but no actual injection is carried out).
Slovenian: V dveh študijah so zdravilo Lucentis primerjali z navideznimi injekcijami (postopkom, podobnim injiciranju zdravila Lucentis, pri katerem se injekcijska brizga prisloni ob površino očesa, do samega injiciranja pa ne pride).